1575 related articles for article (PubMed ID: 16838323)
1. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
[TBL] [Abstract][Full Text] [Related]
2. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT.
Bader P; Beck J; Frey A; Schlegel PG; Hebarth H; Handgretinger R; Einsele H; Niemeyer C; Benda N; Faul C; Kanz L; Niethammer D; Klingebiel T
Bone Marrow Transplant; 1998 Mar; 21(5):487-95. PubMed ID: 9535041
[TBL] [Abstract][Full Text] [Related]
3. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin.
Sufliarska S; Minarik G; Horakova J; Bodova I; Bojtarova E; Czako B; Mistrik M; Drgona L; Demitrovicova M; Lakota J; Krivosikova M; Kovacs L
Neoplasma; 2007; 54(5):424-30. PubMed ID: 17688372
[TBL] [Abstract][Full Text] [Related]
4. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study.
Choi SJ; Lee KH; Lee JH; Kim S; Chung HJ; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Aug; 26(3):327-32. PubMed ID: 10967574
[TBL] [Abstract][Full Text] [Related]
6. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation.
Buño I; Nava P; Simón A; González-Rivera M; Jiménez JL; Balsalobre P; Serrano D; Carrión R; Gómez-Pineda A; Díez-Martín JL
Haematologica; 2005 Oct; 90(10):1373-9. PubMed ID: 16219574
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of interphase fluorescence in situ hybridization monitoring chimeric status after sex-mismatched allogeneic hematopoietic stem cell transplantation for leukemia].
Liu Q; Song L; Zhang Y; Wei Y; Xu D; Sun J; Liu X; Xu B; Meng F; Zhou S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):212-5. PubMed ID: 15793790
[TBL] [Abstract][Full Text] [Related]
8. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia.
Barrios M; Jiménez-Velasco A; Román-Gómez J; Madrigal ME; Castillejo JA; Torres A; Heiniger A
Haematologica; 2003 Jul; 88(7):801-10. PubMed ID: 12857560
[TBL] [Abstract][Full Text] [Related]
9. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
[TBL] [Abstract][Full Text] [Related]
10. Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemia.
Huisman C; de Weger RA; de Vries L; Tilanus MG; Verdonck LF
Bone Marrow Transplant; 2007 Mar; 39(5):285-91. PubMed ID: 17262061
[TBL] [Abstract][Full Text] [Related]
11. Highly sensitive patient-specific real-time PCR SNP assay for chimerism monitoring after allogeneic stem cell transplantation.
Eshel R; Vainas O; Shpringer M; Naparstek E
Lab Hematol; 2006; 12(1):39-46. PubMed ID: 16513545
[TBL] [Abstract][Full Text] [Related]
12. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
[TBL] [Abstract][Full Text] [Related]
13. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
Bader P; Kreyenberg H; Hoelle W; Dueckers G; Handgretinger R; Lang P; Kremens B; Dilloo D; Sykora KW; Schrappe M; Niemeyer C; Von Stackelberg A; Gruhn B; Henze G; Greil J; Niethammer D; Dietz K; Beck JF; Klingebiel T
J Clin Oncol; 2004 May; 22(9):1696-705. PubMed ID: 15117992
[TBL] [Abstract][Full Text] [Related]
14. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of chimerism in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation].
Furukawa T; Hashimoto S; Inano K; Yamazaki F; Takeda H; Kakihara T; Yano T; Abe T; Higuchi W; Toba K; Takahashi M; Koike T; Aizawa Y
Rinsho Ketsueki; 2001 Jun; 42(6):488-95. PubMed ID: 11505528
[TBL] [Abstract][Full Text] [Related]
17. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
[TBL] [Abstract][Full Text] [Related]
18. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms.
Jiménez-Velasco A; Barrios M; Román-Gómez J; Navarro G; Buño I; Castillejo JA; Rodríguez AI; García-Gemar G; Torres A; Heiniger AI
Leukemia; 2005 Mar; 19(3):336-43. PubMed ID: 15674363
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.
Kröger N; Zagrivnaja M; Schwartz S; Badbaran A; Zabelina T; Lioznov M; Ayuk F; Zander A; Fehse B
Exp Hematol; 2006 May; 34(5):688-94. PubMed ID: 16647575
[TBL] [Abstract][Full Text] [Related]
20. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
